Notifications
Back
E2BIO

Our Vision

E2BIO is a company created based on the 20-year tradition of Korea's No. 1 premium spa EIR.


As a subsidiary of Ewha Womans University's technology holding company,

it has a patent for "natural substances derived from marine sedimentary soil" and aims to replace expensive overseas imported cosmetics.

E2BIO's vision is to be recognized by customers who are tamed at the level and level of imported cosmetics for their domestic functional cosmetics.

A subsidiary of Ewha Womans University Technology Holdings.
A subsidiary of Ewha Womans University Technology Holdings.
A company certified by the Ministry of Science and ICT.
A company certified by the Ministry of Science and ICT.
Antranylic acid, which has patented technology for natural substances.
Antranylic acid, which has patented technology for natural substances.
No. 1 premium spa with 20 years of tradition.
No. 1 premium spa with 20 years of tradition.

Our Vision

E2BIO is a company created based on the 20-year tradition of Korea's No. 1 premium spa EIR.


As a subsidiary of Ewha Womans University's technology holding company,

it has a patent for "natural substances derived from marine sedimentary soil" and aims to replace expensive overseas imported cosmetics.

E2BIO's vision is to be recognized by customers who are tamed at the level and level of imported cosmetics for their domestic functional cosmetics.

A subsidiary of Ewha Womans University Technology Holdings.
A company certified by the Ministry of Science and ICT.
Antranylic acid, which has patented technology for natural substances.
No. 1 premium spa with 20 years of tradition.

History

2001 - the present

2020

E2Bio, a subsidiary of Ewha Womans University, was established.
Registered as INCI International Raw Materials for Whitening Function.

Selection of R&D support project by R&D Special Zone Promotion Agency.

Selection of Chungbuk Techno Park R&D Support Project. 

2019

Occupation of Ewha Womans University University-Industry Cooperation Building.
Selection of the Seoul Business Agency (SBA) Technology Commercialization Support Project.
A number of KOTRA projects selected.
Winning the Minister of SMEs and Startups Award.

2018

The start of a business to manufacture functional cosmetics.
Selected R&D projects to support the growth of science and technology research institutes.
Ewha Womans University Patent Exclusive Implementation Agreement.
The technology value evaluation of the Agricultural Technology Practicalization Foundation for 3 patents worth USD 17,000+.

2017

Registered as a cosmetics manufacturer.

Three cases of patent technology transfer.
Establishment of a research institute certified by the Ministry of Science and Technology.
Certification of venture companies.
Establishment of an affiliated research institute.

2014

Opening of 3 Spa direct managed office at Incheon International Airport.

Achieved No. 1 sales in the domestic premium brand spa industry.

2011

Establishing a premium spa brand “Dermalogica SPA”

2009

Development of "Skin Story" brand and franchise business.

2008

The SPA franchise business is launched.

2001

Launching SPA brand service.

Certification

E2BIO Co., Ltd. is a certified research institute company by the Ministry of Science and Technology registered in Cheongju Gangso Special Zone.

Certification

E2BIO Co., Ltd. is a certified research institute company by the Ministry of Science and Technology registered in Cheongju Gangso Special Zone.

Our Team



          KIM SOO-JIN

          CEO


          Master of Hyangjang Beauty at Chung-Ang University.
          CEO of E2Bio.
          CEO of Spa EIR.
          President of the Korean Society for Aroma Research.
          The head of the cooperative association of the Korean Society of Aroma Research.



Kwon Young-il

E2BIO Co., Ltd. Research Director

Academic Background

Ph.D. in Engineering at Seoul National University

Experience
Samsung SDI Production Technology Research Institute Researcher

Researcher, Computer Science Research Institute, Seoul Women's University

Director of Research and Development at ESIO Lab Co., Ltd.

Director of E2BIO Research Institute

Professor Lim Kyung-min

Ewha Womans Univ. College of Pharmacy

Academic Background

Bachelor of Pharmacy at Seoul National University
Master of Pharmacy at Seoul National University
Doctor of Pharmacy at Seoul National University

Experience
Technical Researcher at Amorepacific
Dean of Pharmaceutical Industry at Ewha Womans University Graduate School
Associate professor at Ewha Womans University's College of Pharmacy


Main field of study

Conducting pharmacotoxicity research on new drugs, cosmetics, and health functional foods
A Study on the Alternative Method of Animal Experiment, Skin Toxicity/Pharmacopoeia, and Circulatory Toxicity

Thesis and Patents
16-Kauren-2-beta-18,19-triol inhibits melanosome transport in melanocytes by down-regulation of melanophilin expression
Antithrombotic effect of SP-8008, a benzoic acid derivative, through the selective inhibition of shear stress-induced platelet aggregation
Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility Marine natural products with monoamine oxidase (MAO) inhibitory activity
Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin™ for OECD test guideline 439
Arsenic May Act as a Pro-Metastatic Carcinogen Through Promoting Tumor Cell-Induced Platelet Aggregation 


Professor Nam Sang-jip

Ewha Womans Univ. College of Natural Sciences

Academic Background

Bachelor of Science at Department of Global Environment, Seoul National University (major in Oceanography)
Master of Oceanography at Seoul National University (Major in Ocean Natural Chemistry)
Ph.D. in Oceanography at Seoul National University (Major in Ocean Natural Chemistry)

Experience
Post-doctoral researcher at UCSD Scripps Marine Research Institute
Professor of Pharmacy at Sunchon University
associate professor at Ewha Womans University College of Natural Sciences


Main field of study

Research on the discovery of new natural substances and the development of cosmetics materials for the treatment of diseases
Finding new antibiotics to treat antibiotic-resistant bacteria, tuberculosis bacteria/pathogenic bacteria infection
A Study on the discovery of cancer prevention effective substances from natural materials and the mechanism of action
Natural substances for treatment of central nervous system(CNS) disorders
Analysis of the components and structures of natural substances of various efficacy for the development of cosmetics materials

Thesis and Patents
Mar. Drugs, 2017, 15, 138, Anti-Pigmentary Effect of (-)-4-Hydroxysattabacin from the Marine-Derived Bacterium Bacillus sp.
Org. Lett., 2016, 9, 2256, Ansalactams B–D Illustrate Further Biosynthetic Plasticity within the Ansamycin Pathway
J. Nat Prod., 2015, 78, 368, Monanchosterols A and B, Bioactive Bicyclo[4.3.1]steroids from a Korean Sponge Monanchora sp.
Within the last 5 years, 30 papers on the structure and efficacy of natural substances have been kept (including co-authors)
Composition containing 4-hydroxysattabacin (patent registration, KR101704922B1- SK Bioland technology transfer)
Prevention, improvement or treatment and prevention of pigmentation containing acremondin E (patent registration - EIR technology transfer)